Interference of methysergide, a specific 5-hydroxytryptamine receptor antagonist, with airway chronic allergic inflammation and remodelling in a murine model of asthma

Clinical and Experimental Allergy

Volumn 37, Issue 5, 2007, Pages 723-734

  Lima, C ^a,b   Souza, V M O ^c   Soares, A L ^b   Macedo, M S ^b   Tavares De Lima, W ^b   Vargaftig, B B ^b  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

5 hydroxytryptamine; Asthma; Lung remodelling; Methysergide; Prolonged allergen exposure

Indexed keywords

ALLERGEN; ANTIGEN; COLLAGEN; CYTOKINE; FIBRONECTIN; GAMMA INTERFERON; IMMUNOGLOBULIN E; METHYSERGIDE; NEUTRALIZING ANTIBODY; OVALBUMIN; SEROTONIN; SEROTONIN ANTAGONIST;

AEROSOL; ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CHRONIC INFLAMMATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHILIA; HISTOPATHOLOGY; IMMUNIZATION; IN VITRO STUDY; INHIBITION KINETICS; LUNG LAVAGE; LUNG PARENCHYMA; LYMPH NODE; MALE; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; PROVOCATION TEST; RAT; RESPIRATORY TRACT ALLERGY; SPLEEN; TH2 CELL; TISSUE DISTRIBUTION;

ALLERGENS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; EOSINOPHILIA; IMMUNOGLOBULIN E; INTERFERON TYPE II; MALE; METHYSERGIDE; MICE; MICE, INBRED BALB C; OVALBUMIN; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN ANTAGONISTS;

EID: 34247343774     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02700.x     Document Type: Article

References (68)

1. Roche WR, Beasley R, Williams JH, Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989 1: 520 4.
2. Brewster CE, Howarth PH, Djukanovic R, Wilson J, Holgate ST, Roche WR. Myofibroblasts and subepithelial fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1990 3: 507 11.
3. Roberts CR. Is asthma a fibrotic disease? Chest 1995 107: 111S 7S.
4. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airway. Clin Exp Allergy 1997 27: 363 71.
5. Chu HW, Halliday JL, Martin RJ, Leung DY, Szefler SJ, Wenzel SE. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 1998 158: 1936 44.
6. James AL, Paré PD, Hogg JC. The mechanisms of airway narrowing in asthma. Am Rev Respir Dis 1989 139: 242 6.
7. Kay AB, Phipps S, Robinson DS. A role for eosinophils in airway remodelling in asthma. Trends Immunol 2004 25: 477 82.
8. Humbles AA, Lloyd CM, Mcmillan SJ et al. A critical role for eosinophils in allergic airways remodeling. Science 2004 305: 1776 9.
9. Flood-Page P, Menzies-Gow A, Phipps S et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003 112: 1029 36.
10. McMillan SJ, Lloyd CM. Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004 34: 497 507.
11. Snibson KJ, Bischof RJ, Slocombe RF, Meeusen EN. Airway remodelling and inflammation in sheep lungs after chronic airway challenge with house dust mite. Clin Exp Allergy 2005 35: 146 52.
12. Dvorak AM, Tepper RI, Weller PF et al. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructural cytochemistry. Blood 1994 83: 3600 12.
13. Nagai H, Yamaguchi S, Maeda Y, Tanaka H. Role of mast cells, eosinophils and IL-5 in the development of airway hyperresponsiveness in sensitized mice. Clin Exp Allergy 1996 26: 642 7.
14. Matkar NM, Rupwate RU, Desai NK, Kamat SR. Comparative study of platelet histamine and serotonin with their corresponding plasma oxidases in asthmatics with normals. J Assoc Physicians India 1999 47: 878 82.
15. Eum SY, Norel X, Lefort J, Labat C, Vargaftig BB, Brink C. Anaphylactic bronchoconstriction in BP2 mice: interactions between serotonin and acetylcholine. Br J Pharmacol 1999 126: 312 6.
16. Idzko M, Panther E, Stratz C et al. The serotoninergic receptors of human dendritic cells: identification and coupling to cytokine release. J Immunol 2004 172: 6011 9.
17. Hoyer D, Clarke DE, Fozard JR et al. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 1994 46: 157 203.
18. Ullmer C, Schmuck K, Kalkman HO, Lubbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett 1995 370: 215 21.
19. MacLean MR, Herve P, Eddahibi S, Adnot S. 5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 2000 131: 161 8.
20. Bayer H, Muller T, Myrtek D et al. Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol 2007 36: 85 93.
21. Young MR, Kut JL, Coogan MP, Wright MA, Young ME, Matthews J. Stimulation of splenic T-lymphocyte function by endogenous serotonin and by low-dose exogenous serotonin. Immunology 1993 80: 395 400.
22. Iken K, Chheng S, Fargin A, Goulet AC, Kouassi E. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cell Immunol 1995 163: 1 9.
23. Laberge S, Cruikshank WW, Beer DJ, Center DM. Secretion of IL-16 (lymphocyte chemoattractant factor) from serotonin-stimulated CD8+T cells in vitro. J Immunol 1996 156: 310 5.
24. Cloez-Tayarani I, Petit-Bertron AF, Venters HD, Cavaillon JM. Differential effect of serotonin on cytokine production in lipopolysaccharide- stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors. Int Immunol 2003 15: 233 40.
25. Lima C, Souza VMO, Faquim-Mauro EL et al. Modulation of the induction of lung and airway allergy in the offspring of IFN-γ-treated mother mice. J Immunol 2005 175: 3554 9.
26. Little FF, Lynch E, Fine G, Center DM, Cruikshank WW. Tumor necrosis factor-alpha-induced synthesis of interleukin-16 in airway epithelial cells: priming for serotonin stimulation. Am J Respir Cell Mol Biol 2003 28: 354 62.
27. Fozard JR, Leach GDH. The hypotensive action of 5-hydroxytryptamine (5-HT) in anaesthetised and pithed rats. Eur J Pharmacol 1968 2: 239 49.
28. Hannon JP, Tigani B, Williams I, Mazzoni L, Fozard JR. Mechanism of airway hyperresponsiveness to adenosine induced by allergen challenge in actively sensitized Brown Norway rats. Br J Pharmacol 2001 132: 1509 23.
29. Mota I, Wong D. Homologous passive cutaneous anaphylactic activity of mouse antiserum during the course of immunization. Life Sci 1969 8: 813 20.
30. Proust B, Nahori MA, Ruffie C, Lefort J, Vargaftig BB. Persistence of bronchopulmonary hyper-reactivity and eosinophilic lung inflammation after anti-IL-5 or -IL-13 treatment in allergic BALB/c and IL-4Ralpha knockout mice. Clin Exp Allergy 2003 33: 119 31.
31. Rennard SI, Berg R, Martin GR, Foidart JM, Robey PG. Enzyme-linked immunoassay (ELISA) for connective tissue components. Anal Biochem 1980 104: 205 14.
32. Reinhardt AK, Bottoms SE, Laurent GJ, McAnulty RJ. Quantification of collagen and proteoglycan deposition in a murine model of airway remodelling. Respir Res 2005 8: 6 30.
33. Hodge G, Hodge S, Reynolds PN, Holmes M. Compartmentalization of intracellular proinflammatory cytokines in bronchial intraepithelial T cells of stable lung transplant patients. Clin Exp Immunol 2006 145: 413 9.
34. Trifilieff A, El Hashim A, Bertrand C. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 2000 279: L1120 8.
35. Komai M, Tanaka H, Masuda T et al. Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma. Br J Pharmacol 2003 138: 912 20.
36. Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM. Predominant Th2 like broncoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992 326: 298 304.
37. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996 383: 787.
38. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. Interferon-γ regulates the isotypes of immunoglobulin secreted during in vivo humoral immune responses. J Immunol 1988 140: 1022.
39. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12Rß2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997 185: 817.
40. Iwamoto I, Nakajima H, Endo H, Yoshida S. Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+T cells. J Exp Med 1993 177: 573.
41. Nakajima H, Iwamoto I, Yoshida S. Aerosolized recombinant interferon-gamma prevents antigen-induced eosinophil recruitment in mouse trachea. Am Rev Respir Dis 1993 148: 1102.
42. Li XM, Chopra RK, Chou TY, Schofield BH, Wills-Karp M, Huang SK. Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol 1996 157: 3216.
43. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999 103: 175.
44. Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD. Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999 162: 2375.
45. Cohn L, Homer RJ, Niu N, Bottomly K. T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production. J Exp Med 1999 190: 1309 18.
46. Laitinen A, Laitinen LA. Vascular beds in the airways of normal subjects and asthmatics. Eur Respir J 1990 12: 658s 62s.
47. Regnard J, Lockhart A. Vascular factors in bronchial hyperresponsiveness and asthma. Respir Med 1992 86: 179 81.
48. McFadden ER Jr., Gilbert IA. Asthma. N Engl J Med 1992 327: 1928 37.
49. Launay JM, Herve P, Peoc'h K et al. Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med 2002 8: 1129 35.
50. Tang W, Geba GP, Zheng T et al. Targeted expression of IL-11 in the murine airway causes lymphocytic inflammation, bronchial remodeling, and airways obstruction. J Clin Invest 1996 98: 2845 53.
51. Kenyon NJ, Ward RW, Mcgrew G, Last JA. TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 2003 58: 772 7.
52. Cho JY, Miller M, Baek KJ et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004 113: 551 60.
53. Trifilieff A, Fujitani Y, Coyle AJ, Kopf M, Bertrand C. IL-5 deficiency abolishes aspects of airway remodelling in a murine model of lung inflammation. Clin Exp Allergy 2001 31: 934 42.
54. Dunford PJ, O'Donnell N, Riley JP, Williams KN, Karlsson L, Thurmond RL. The histamine H4 receptor mediates allergic airway inflammation by regulating the activation of CD4+T cells. J Immunol 2006 176: 7062 70.
55. Brightling CE, Bradding P, Pavord ID, Wardlaw AJ. New insights into the role of the mast cell in asthma. Clin Exp Allergy 2003 33: 550 6.
56. Suto H Nakae S, Kakurai M, Sedgwick JD, Tsai M, Galli SJ. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 2006 176: 4102 12.
57. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006 117: 1277 84.
58. Kanbe N, Kurosawa M, Nagata H, Saito H, Miyachi T. Cord blood-derived cultured human mast cells produce transforming growth factor beta1. Clin Exp Allergy 1999 29: 105 13.
59. Dahlen B, Shute J, Howarth P. Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 1999 54: 590 6.
60. Masuda T, Tanaka H, Komai M et al. Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin Exp Allergy 2003 33: 705 13.
61. Yu M, Tsai M, Tam SY, Jones C, Zehnder J, Galli SJ. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 2006 116: 1633 41.
62. Bradding P. The role of the mast cell in asthma: a reassessment. Curr Opin Allergy Clin Immunol 2003 3: 45 50.
63. Kitamura Y. Heterogeneity of mast cells and phenotypic change between subpopulations. Ann Rev Immunol 1989 7: 59 66.
64. Rand TH, Cruikshank WW, Center DM, Weller PF. CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligand elicit eosinophil migration. J Exp Med 1991 173: 1521 8.
65. Center DM, Berman JS, Kornfeld H, Theodore AC, Cruikshank WW. The lymphocyte chemoattractant factor. J Lab Clin Med 1995 125: 167 72.
66. Boehme SA, Lio FM, Sikora L et al. Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin. J Immunol 2004 173: 3599 603.
67. Young MR, Matthews JP. Serotonin regulation of T-cell subpopulations and of macrophage accessory function. Immunology 1995 84: 148 52.
68. O'Connell PJ, Wang X, Leon-Ponte M, Griffiths C, Pingle SC, Ahern GP. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 2006 107: 1010 7.